Latest Advances

  • Condition: Myocarditis
  • Journal: Autoimmunity reviews
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: NULL
  • Published —
In this study, researchers evaluated the effectiveness of immunosuppressive therapy for the treatment of myocarditis.
  • Condition: COVID-19 Fulminant Myopericarditis and Acute Respiratory Distress Syndrome (ARDS) in Middle-Aged Male Patient
  • Journal: Cureus
  • Treatment Used: Hydroxychloroquine, Azithromycin, Dobutamine, Remdesivir, and Ventilatory Support
  • Number of Patients: 1
  • Published —
This case report describes a 51-year-old man diagnosed with coronavirus (COVID-19) fulminant myopericarditis and acute respiratory distress syndrome (ARDS) treated with hydroxychloroquine, azithromycin, dobutamine, remdesivir, and ventilatory support.
  • Condition: COVID-19
  • Journal: Cardiovascular research
  • Treatment Used: Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors
  • Number of Patients: 0
  • Published —
This article discusses cardiovascular complications in patients with COVID-19 and their treatments.
  • Condition: COVID-19 Complicated with Fulminant Myocarditis
  • Journal: Infection
  • Treatment Used: Antiviral Therapy and Mechanical Life Support
  • Number of Patients: 1
  • Published —
This case report describes a 63-year-old male diagnosed with COVID-19 complicated with fulminant myocarditis (heart inflammation) treated with antiviral therapy and mechanical life support.
  • Condition: Pediatric Patients With Acute Myocarditis
  • Journal: Scientific reports
  • Treatment Used: effectiveness of intravenous immunoglobulin therapy
  • Number of Patients: 1404
  • Published —
The purpose of the study was to assess the benefits of intravenous immunoglobulin therapy for the treatment of pediatric patients with acute myocarditis.
Showing 1-6 of 6